person · Reporting owner

Bujarski Robert Joseph

Disclosed activity across 2 companies

Tapewire entity: 86707
SEC CIK: 0001333458

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
QuidelOrtho CorpQDEL · Entity 4986	EVP & COO	October 15, 2024	October 17, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

QuidelOrtho Corp

Report date October 15, 2024 · Filed October 17, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	44,810	Ending reported balance After 2024-10-15 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2024-10-15 · Grant · Acquired 390 · Balance 45,027 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2024-10-15 · Tax withholding · Disposed 217 · Balance 44,810 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	390	Reported balance After 2024-10-15 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2024-10-15 · Exercise / conversion · Disposed 390 · Balance 390 F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4: 390 shares vested on October 15, 2024; the remaining 390 shares will vest on October 15, 2025.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects release of restricted stock units that were previously reported on a Form 4.

F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.

F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

F4: 390 shares vested on October 15, 2024; the remaining 390 shares will vest on October 15, 2025.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

QUIDEL CORP /DE/

Report date May 27, 2022 · Filed June 01, 2022

Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2022-05-27 transaction · row 1 1 source row Row 1 · 2022-05-27 · Disposition to issuer · Disposed 29,164 · Balance 0 F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $23.41 · Expires 2025-02-05	Direct	Reported balance After 2022-05-27 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2022-05-27 · Disposition to issuer · Disposed 8,798 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $15.40 · Expires 2026-02-10	Direct	Reported balance After 2022-05-27 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-05-27 · Disposition to issuer · Disposed 17,596 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $21.08 · Expires 2027-02-15	Direct	Reported balance After 2022-05-27 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2022-05-27 · Disposition to issuer · Disposed 14,343 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $46.41 · Expires 2028-01-16	Direct	Reported balance After 2022-05-27 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2022-05-27 · Disposition to issuer · Disposed 9,212 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3: Vested in full.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $59.12 · Expires 2029-02-04	Direct	Reported balance After 2022-05-27 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2022-05-27 · Disposition to issuer · Disposed 7,246 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4: 5,435 shares are vested in full; 1,811 shares will vest on February 4, 2023.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $77.16 · Expires 2030-02-03	Direct	Reported balance After 2022-05-27 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2022-05-27 · Disposition to issuer · Disposed 6,641 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5: 3,321 shares are vested in full; the remaining 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $159.39 · Expires 2030-09-14	Direct	Reported balance After 2022-05-27 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2022-05-27 · Disposition to issuer · Disposed 2,935 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F6: 1,467 shares will vest on September 14, 2022; the remaining 1,468 shares will vest in equal installments on September 14, 2023 and September 14, 2024.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $254.00 · Expires 2031-02-01	Direct	Reported balance After 2022-05-27 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2022-05-27 · Disposition to issuer · Disposed 3,514 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F7: 878 shares are vested in full; 878 shares will vest on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025.
Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $103.36 · Expires 2032-01-31	Direct	Reported balance After 2022-05-27 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2022-05-27 · Disposition to issuer · Disposed 12,876 · Balance 0 F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F8: 12,876 shares will vest in equal installments on January 31, 2023, January 31, 2024, January 31, 2025 and January 31, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2022-05-27 · Disposition to issuer · Disposed 3,623 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11: 3,623 shares will vest on February 4, 2023.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2022-05-27 · Disposition to issuer · Disposed 2,749 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2022-05-27 · Disposition to issuer · Disposed 824 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2022-05-27 · Disposition to issuer · Disposed 1,033 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: 1,033 shares will vest on November 18, 2022.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2022-05-27 · Disposition to issuer · Disposed 3,320 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14: 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2022-05-27 · Disposition to issuer · Disposed 1,052 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2022-05-27 · Disposition to issuer · Disposed 315 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2022-05-27 · Disposition to issuer · Disposed 941 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: 313 shares will vest on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · 2022-05-27 · Disposition to issuer · Disposed 1,351 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · 2022-05-27 · Disposition to issuer · Disposed 405 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 21 Instrument identity requires review; Table II rows are not merged. 1 source row Row 21 · 2022-05-27 · Disposition to issuer · Disposed 2,637 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F16: 2,637 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 22 Instrument identity requires review; Table II rows are not merged. 1 source row Row 22 · 2022-05-27 · Disposition to issuer · Disposed 1,559 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F17: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 23 Instrument identity requires review; Table II rows are not merged. 1 source row Row 23 · 2022-05-27 · Disposition to issuer · Disposed 12,878 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F18: 3,219 shares will vest on each of January 31, 2023 and January 31, 2024; 3,220 shares will vest on each of January 31, 2025 and January 31, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 24 Instrument identity requires review; Table II rows are not merged. 1 source row Row 24 · 2022-05-27 · Disposition to issuer · Disposed 13,545 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F19: 6,772 shares will vest on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 25 Instrument identity requires review; Table II rows are not merged. 1 source row Row 25 · 2022-05-27 · Disposition to issuer · Disposed 1,190 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2022-05-27 transaction · row 26 Instrument identity requires review; Table II rows are not merged. 1 source row Row 26 · 2022-05-27 · Disposition to issuer · Disposed 357 · Balance 0 F9: Each restricted stock unit represents the right to receive one share of Quidel common stock. F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F20: 357 shares will vest on January 31, 2023.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.

F2: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F3: Vested in full.

F4: 5,435 shares are vested in full; 1,811 shares will vest on February 4, 2023.

F5: 3,321 shares are vested in full; the remaining 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.

F6: 1,467 shares will vest on September 14, 2022; the remaining 1,468 shares will vest in equal installments on September 14, 2023 and September 14, 2024.

F7: 878 shares are vested in full; 878 shares will vest on February 1, 2023; the remaining 1,758 shares will vest in equal installments on February 1, 2024 and February 1, 2025.

F8: 12,876 shares will vest in equal installments on January 31, 2023, January 31, 2024, January 31, 2025 and January 31, 2026.

F9: Each restricted stock unit represents the right to receive one share of Quidel common stock.

F10: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).

F11: 3,623 shares will vest on February 4, 2023.

F12: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.

F13: 1,033 shares will vest on November 18, 2022.

F14: 3,320 shares will vest in equal installments on February 3, 2023 and February 3, 2024.

F15: 313 shares will vest on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024.

F16: 2,637 shares will vest in equal installments on February 1, 2023, February 1, 2024 and February 1, 2025.

F17: 389 shares will vest on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025.

F18: 3,219 shares will vest on each of January 31, 2023 and January 31, 2024; 3,220 shares will vest on each of January 31, 2025 and January 31, 2026.

F19: 6,772 shares will vest on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026.

F20: 357 shares will vest on January 31, 2023.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 03, 2021 Filed Feb 5, 2021 18:47 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionRestricted Stock Units · Derivative	1,661	$0.00	$0.00	Disclosure SEC source: 0001209191-21-008293 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,980 Underlying: Common Stock · 1,661 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 1,661 shares vested on the first anniversary date of the grant date, February 3, 2021. F4 · derivative.expiration_date: 1,661 shares vested on the first anniversary date of the grant date, February 3, 2021. Read SEC document
February 03, 2021 Filed Feb 5, 2021 18:47 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	791	$236.85	$187,348.35	Disclosure SEC source: 0001209191-21-008293 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,929 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 03, 2021 Filed Feb 5, 2021 18:47 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	1,661	$0.00	$0.00	Disclosure SEC source: 0001209191-21-008293 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,720 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
February 01, 2021 Filed Feb 3, 2021 20:43 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantNon-Qualified Stock Option · Derivative	3,514	$0.00 Strike: $254.00	$0.00	Disclosure SEC source: 0001209191-21-007591 · doc4.xml · derivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,514 Underlying: Common Stock · 3,514 shares Expires 2031-02-01 F2 · derivative.exercise_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document
February 01, 2021 Filed Feb 3, 2021 20:43 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units · Derivative	3,516	$0.00	$0.00	Disclosure SEC source: 0001209191-21-007591 · doc4.xml · derivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,516 Underlying: Common Stock · 3,516 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F2 · derivative.exercise_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. F2 · derivative.expiration_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document
January 11, 2021 Filed Jan 13, 2021 19:34 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units (Premium) · Derivative	405	$0.00	$0.00	Disclosure SEC source: 0001209191-21-003482 · doc4.xml · derivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 405 Underlying: Common Stock · 405 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F4 · derivative.exercise_date: The restricted stock units vest on the first anniversary date of the grant date, January 11, 2022. F3 · derivative.expiration_date: The restricted stock units were received in lieu of a percentage of the reporting person's 2020 cash bonus pursuant to the Quidel Corporation Deferred Bonus Compensation Plan. Read SEC document
January 11, 2021 Filed Jan 13, 2021 19:34 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units (Converted) · Derivative	1,351	$0.00	$0.00	Disclosure SEC source: 0001209191-21-003482 · doc4.xml · derivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,351 Underlying: Common Stock · 1,351 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on the date of the grant, January 11, 2021. F3 · derivative.expiration_date: The restricted stock units were received in lieu of a percentage of the reporting person's 2020 cash bonus pursuant to the Quidel Corporation Deferred Bonus Compensation Plan. Read SEC document
November 18, 2020 Filed Nov 20, 2020 20:11 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionRestricted Stock Units · Derivative	1,034	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059834 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,066 Underlying: Common Stock · 1,034 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 1,034 shares vested on the first anniversary date of the grant date, November 18, 2020. 1,033 shares will vest on the second anniversary date of the grant date, November 18, 2021. 1,033 shares will vest on the third anniversary date of the grant date, November 18, 2022. F4 · derivative.expiration_date: 1,034 shares vested on the first anniversary date of the grant date, November 18, 2020. 1,033 shares will vest on the second anniversary date of the grant date, November 18, 2021. 1,033 shares will vest on the third anniversary date of the grant date, November 18, 2022. Read SEC document
November 18, 2020 Filed Nov 20, 2020 20:11 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	358	$187.28	$67,046.24	Disclosure SEC source: 0001209191-20-059834 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,059 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
November 18, 2020 Filed Nov 20, 2020 20:11 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	1,034	$0.00	$0.00	Disclosure SEC source: 0001209191-20-059834 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,417 F1 · price: Reflects the release of restricted stock units that were previously reported on a Form 4. Read SEC document
September 14, 2020 Filed Sep 16, 2020 21:34 UTC Amendment	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantNon-Qualified Stock Options · Derivative	2,935	$0.00 Strike: $159.39	$0.00	Disclosure SEC source: 0001209191-20-050784 · doc4a.xml · derivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,935 Underlying: Common Stock · 2,935 shares Expires 2030-09-14 F3 · derivative.exercise_date: 1,467 shares will vest on the second anniversary date of the grant date, September 14, 2022. 734 shares will vest on the third anniversary date of the grant date, September 14, 2023. 734 shares will vest on the fourth anniversary date of the grant date, September 14, 2024. Read SEC document
September 14, 2020 Filed Sep 16, 2020 21:34 UTC Amendment	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units · Derivative	1,254	$0.00	$0.00	Disclosure SEC source: 0001209191-20-050784 · doc4a.xml · derivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,254 Underlying: Common Stock · 1,254 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F2 · derivative.exercise_date: 313 shares will vest on the first anniversary date of the grant date, September 14, 2021. 313 shares will vest on the second anniversary date of the grant date, September 14, 2022. 314 shares will vest on the third anniversary date of the grant date, September 14, 2023. 314 shares will vest on the fourth anniversary date of the grant date, September 14, 2024. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. Read SEC document
September 14, 2020 Filed Sep 16, 2020 19:03 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantNon-Qualified Stock Options · Derivative	2,935	$0.00 Strike: $68.14	$0.00	Disclosure SEC source: 0001209191-20-050767 · doc4.xml · derivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,935 Underlying: Common Stock · 2,935 shares Expires 2030-09-14 F3 · derivative.exercise_date: 1,467 shares will vest on the second anniversary date of the grant date, September 14, 2022. 734 shares will vest on the third anniversary date of the grant date, September 14, 2023. 734 shares will vest on the fourth anniversary date of the grant date, September 14, 2024. Read SEC document
September 14, 2020 Filed Sep 16, 2020 19:03 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units · Derivative	1,254	$0.00	$0.00	Disclosure SEC source: 0001209191-20-050767 · doc4.xml · derivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,254 Underlying: Common Stock · 1,254 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F2 · derivative.exercise_date: 313 shares will vest on the first anniversary date of the grant date, September 14, 2021. 313 shares will vest on the second anniversary date of the grant date, September 14, 2022. 314 shares will vest on the third anniversary date of the grant date, September 14, 2023. 314 shares will vest on the fourth anniversary date of the grant date, September 14, 2024. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. Read SEC document
May 20, 2020 Filed May 22, 2020 19:59 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	SaleCommon Stock	20,000	$189.41	$3,788,282.00	Disclosure SEC source: 0001209191-20-031880 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, NA Comm Ops & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,383 F1 · price: The weighted average sale price for these transactions was $189.4141 per share, with a range of $185.705 to $191.62. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document
February 16, 2020 Filed Feb 19, 2020 20:06 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	355	$80.40	$28,542.00	Disclosure SEC source: 0001209191-20-010821 · doc4.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · SVP, NA Comm Ops & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,383 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 16, 2020 Filed Feb 19, 2020 20:06 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	1,025	$0.00	$0.00	Disclosure SEC source: 0001209191-20-010821 · doc4.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · SVP, NA Comm Ops & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,738 F1 · shares: Reflects vesting of restricted stock units which were previously reported on a Form 4. Read SEC document
February 16, 2020 Filed Feb 19, 2020 20:06 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	1,102	$80.40	$88,600.80	Disclosure SEC source: 0001209191-20-010821 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, NA Comm Ops & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,713 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 16, 2020 Filed Feb 19, 2020 20:06 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	3,419	$0.00	$0.00	Disclosure SEC source: 0001209191-20-010821 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, NA Comm Ops & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,815 F1 · shares: Reflects vesting of restricted stock units which were previously reported on a Form 4. Read SEC document
February 10, 2020 Filed Feb 12, 2020 20:05 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units (Premium) · Derivative	315	$0.00	$0.00	Disclosure SEC source: 0001209191-20-009029 · doc4.xml · derivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · SVP, NA Comm Ops & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315 Underlying: Common Stock · 315 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F6 · derivative.exercise_date: The restricted stock units vest on the first anniversary date of the grant date, February 10, 2021. F5 · derivative.expiration_date: The restricted stock units were received in lieu of a percentage of the reporting person's 2019 cash bonus pursuant to the Quidel Corporation Deferred Bonus Compensation Plan. Read SEC document
February 10, 2020 Filed Feb 12, 2020 20:05 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units (Converted) · Derivative	1,052	$0.00	$0.00	Disclosure SEC source: 0001209191-20-009029 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · SVP, NA Comm Ops & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,052 Underlying: Common Stock · 1,052 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F4 · derivative.exercise_date: The restricted stock units vest on the date of grant, February 10, 2020. F5 · derivative.expiration_date: The restricted stock units were received in lieu of a percentage of the reporting person's 2019 cash bonus pursuant to the Quidel Corporation Deferred Bonus Compensation Plan. Read SEC document
February 10, 2020 Filed Feb 12, 2020 20:05 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	490	$77.52	$37,984.80	Disclosure SEC source: 0001209191-20-009029 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, NA Comm Ops & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,396 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 10, 2020 Filed Feb 12, 2020 20:05 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	1,201	$0.00	$0.00	Disclosure SEC source: 0001209191-20-009029 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, NA Comm Ops & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,886 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document
February 03, 2020 Filed Feb 5, 2020 20:27 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Unit · Derivative	6,641	$0.00	$0.00	Disclosure SEC source: 0001209191-20-007062 · doc4.xml · derivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, NA Comm Ops & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,641 Underlying: Common Stock · 6,641 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F1 · derivative.exercise_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. F1 · derivative.expiration_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document
February 03, 2020 Filed Feb 5, 2020 20:27 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantNon-Qualified Stockk Options · Derivative	6,641	$0.00 Strike: $77.16	$0.00	Disclosure SEC source: 0001209191-20-007062 · doc4.xml · derivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, NA Comm Ops & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,641 Underlying: Common Stock · 6,641 shares Expires 2030-02-03 F1 · derivative.exercise_date: One-quarter of the shares will vest annually over a four-year period, commencing on the first anniversary date of the grant date. Read SEC document
November 18, 2019 Filed Nov 20, 2019 19:59 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units · Derivative	3,100	$0.00	$0.00	Disclosure SEC source: 0001209191-19-057534 · doc4.xml · derivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, NA Comm Ops & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,100 Underlying: Common Stock · 3,100 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F2 · derivative.exercise_date: 1,034 shares will vest on the first anniversary date of the grant date, November 18, 2020. 1,033 shares will vest on the second anniversary date of the grant date, November 18, 2021. 1,033 shares will vest on the third anniversary date of the grant date, November 18, 2022. F2 · derivative.expiration_date: 1,034 shares will vest on the first anniversary date of the grant date, November 18, 2020. 1,033 shares will vest on the second anniversary date of the grant date, November 18, 2021. 1,033 shares will vest on the third anniversary date of the grant date, November 18, 2022. Read SEC document
February 19, 2019 Filed Feb 21, 2019 20:03 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	SaleCommon Stock	15,000	$65.01	$975,181.50	Disclosure SEC source: 0001209191-19-012331 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,685 F1 · price: The weighted average sale price for these transactions was $65.0121 per share, with a range of $65.00 to $65.43. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document
February 11, 2019 Filed Feb 13, 2019 20:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units (Premium) · Derivative	824	$0.00	$0.00	Disclosure SEC source: 0001209191-19-009916 · doc4.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 824 Underlying: Common Stock · 824 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F6 · derivative.exercise_date: The restricted stock units vest on the first anniversary date of the grant date, February 11, 2020. F5 · derivative.expiration_date: The restricted stock units were received in lieu of a percentage of the reporting person's 2018 cash bonus pursuant to the Quidel Corporation Deferred Bonus Compensation Plan. Read SEC document
February 11, 2019 Filed Feb 13, 2019 20:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units (Converted) · Derivative	2,749	$0.00	$0.00	Disclosure SEC source: 0001209191-19-009916 · doc4.xml · derivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,749 Underlying: Common Stock · 2,749 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, February 11, 2019. F5 · derivative.expiration_date: The restricted stock units were received in lieu of a percentage of the reporting person's 2018 cash bonus pursuant to the Quidel Corporation Deferred Bonus Compensation Plan. Read SEC document
February 11, 2019 Filed Feb 13, 2019 20:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	213	$60.75	$12,939.75	Disclosure SEC source: 0001209191-19-009916 · doc4.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,685 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 11, 2019 Filed Feb 13, 2019 20:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	624	$0.00	$0.00	Disclosure SEC source: 0001209191-19-009916 · doc4.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,898 F1 · shares: Reflects vesting of prior restricted stock units, which were previously reported on a Form 4. Read SEC document
February 11, 2019 Filed Feb 13, 2019 20:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	676	$60.75	$41,067.00	Disclosure SEC source: 0001209191-19-009916 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,274 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 11, 2019 Filed Feb 13, 2019 20:19 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	2,082	$0.00	$0.00	Disclosure SEC source: 0001209191-19-009916 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,950 F1 · shares: Reflects vesting of prior restricted stock units, which were previously reported on a Form 4. Read SEC document
February 10, 2019 Filed Feb 12, 2019 20:29 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	425	$58.37	$24,807.25	Disclosure SEC source: 0001209191-19-009525 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,868 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 10, 2019 Filed Feb 12, 2019 20:29 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	1,201	$0.00	$0.00	Disclosure SEC source: 0001209191-19-009525 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,293 F1 · shares: Reflects vesting of prior restricted stock units, which were previously reported on a Form 4. Read SEC document
February 05, 2019 Filed Feb 6, 2019 21:22 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	490	$59.00	$28,910.00	Disclosure SEC source: 0001209191-19-007936 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,092 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 05, 2019 Filed Feb 6, 2019 21:22 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	1,201	$0.00	$0.00	Disclosure SEC source: 0001209191-19-007936 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,582 F1 · shares: Reflects vesting of prior restricted stock units, which were previously reported on a Form 4. Read SEC document
February 04, 2019 Filed Feb 6, 2019 21:22 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantRestricted Stock Units · Derivative	3,623	$0.00	$0.00	Disclosure SEC source: 0001209191-19-007936 · doc4.xml · derivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,623 Underlying: Common Stock · 3,623 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F5 · derivative.exercise_date: 3,623 shares will vest on the fourth anniversary date of the grant date, February 4, 2023. F5 · derivative.expiration_date: 3,623 shares will vest on the fourth anniversary date of the grant date, February 4, 2023. Read SEC document
February 04, 2019 Filed Feb 6, 2019 21:22 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantNon-Qualified Stock Option · Derivative	7,246	$0.00 Strike: $59.12	$0.00	Disclosure SEC source: 0001209191-19-007936 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,246 Underlying: Common Stock · 7,246 shares Expires 2029-02-04 F3 · derivative.exercise_date: 3,623 shares will vest on the second anniversary date of the grant date, February 4, 2021. 1,812 shares will vest on the third anniversary date of the grant date, February 4, 2022. 1,811 shares will vest on the fourth anniversary date of the grant date, February 4, 2023. Read SEC document
August 17, 2018 Filed Aug 21, 2018 20:02 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionNon-Qualified Stock Options · Derivative	17,596	$0.00 Strike: $15.40	$0.00	Disclosure SEC source: 0001209191-18-047874 · doc4.xml · derivative · entry 7 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,596 Underlying: Common Stock · 17,596 shares Expires 2026-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 17,596 shares vested on 2/10/2018; 8,798 shares will vest on 2/10/2019; 8,798 shares will vest on 2/10/2020. Read SEC document
August 17, 2018 Filed Aug 21, 2018 20:02 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionNon-Qualified Stock Options · Derivative	8,798	$0.00 Strike: $23.41	$0.00	Disclosure SEC source: 0001209191-18-047874 · doc4.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,798 Underlying: Common Stock · 8,798 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 17,596 shares vested on 2/5/2017; 8,798 shares vested on 2/5/2018; 8,798 shares will vest on 2/4/2019. Read SEC document
August 17, 2018 Filed Aug 21, 2018 20:02 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionNon-qualified Stock Options · Derivative	7,156	$0.00 Strike: $27.57	$0.00	Disclosure SEC source: 0001209191-18-047874 · doc4.xml · derivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,156 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 14,130 shares vested on 2/24/2016; 7,155 shares vested on 2/24/2017; 7,156 shares vested on 2/24/2018. Read SEC document
August 17, 2018 Filed Aug 21, 2018 20:02 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	SaleCommon Stock	38,550	$70.15	$2,704,247.81	Disclosure SEC source: 0001209191-18-047874 · doc4.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,381 F1 · price: The weighted average sale price for these transactions was $70.1491 per share, with a range of $69.755 to $70.71. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document
August 17, 2018 Filed Aug 21, 2018 20:02 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionCommon Stock	17,596	$15.40	$270,978.40	Disclosure SEC source: 0001209191-18-047874 · doc4.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 17, 2018 Filed Aug 21, 2018 20:02 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionCommon Stock	8,798	$23.41	$205,961.18	Disclosure SEC source: 0001209191-18-047874 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 17, 2018 Filed Aug 21, 2018 20:02 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Exercise / conversionCommon Stock	7,156	$27.57	$197,290.92	Disclosure SEC source: 0001209191-18-047874 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 28, 2018 Filed Mar 2, 2018 20:00 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	171	$43.62	$7,459.02	Disclosure SEC source: 0001209191-18-016059 · doc4.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,381 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 28, 2018 Filed Mar 2, 2018 20:00 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	495	$0.00	$0.00	Disclosure SEC source: 0001209191-18-016059 · doc4.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,552 F1 · shares: Reflects vesting of prior restricted stock units, which were previously reported on a Form 4. Read SEC document
February 28, 2018 Filed Mar 2, 2018 20:00 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	Tax withholdingCommon Stock	532	$43.62	$23,205.84	Disclosure SEC source: 0001209191-18-016059 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,057 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document
February 28, 2018 Filed Mar 2, 2018 20:00 UTC	QUIDEL CORP /DE/ QDEL · Entity 126712	GrantCommon Stock	1,651	$0.00	$0.00	Disclosure SEC source: 0001209191-18-016059 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · SVP, Bus Dev & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,589 F1 · shares: Reflects vesting of prior restricted stock units, which were previously reported on a Form 4. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.